human papillomavirus (HPV). Papillomavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention 1: The intervention group will receive vaginal probiotic capsules (with the trade name Lacto vag, manufactured by the American Food and Drug Company, a pack of 30), two vaginal capsules p
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
21 Years to 65 Years
Inclusion criteria
Inclusion criteria: Informed consent Age 21-65 years married being in the follicular period of the menstrual cycle; Not having intercourse and not washing the vagina in the last 48 hours
Exclusion criteria
Exclusion criteria: Pregnant, lactating and smoking women People who are considered sick based on clinical diagnosis but whose test results are negative Using vaginal drugs such as creams, suppositories and vaginal disinfectants in the last 48 hours Suffering from certain diseases such as liver, heart, kidney disease, diabetes, central nervous system diseases, blood dyscrasias, immune system defects and known sexually transmitted diseases. Use of broad-spectrum antibiotics, antiprostaglandins, hormonal and immunosuppressive drugs, alcohol, and anticoagulant drugs during the last month
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Wet smear. Timepoint: 6 months after the start of the study. Method of measurement: Pap smear test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Saba Najafi
Kermanshah University of Medical Sciences
Outcome results
None listed